The DOI matches its Crossref record; 62 of the 64 references it cites were found in a registry or an index.
Circular RNAs are long-lived and display only minimal early alterations in response to a growth factor
Open accessAbstract
Circular RNAs (circRNAs) are widespread circles of non-coding RNAs with largely unknown function. Because stimulation of mammary cells with the epidermal growth factor (EGF) leads to dynamic changes in the abundance of coding and non-coding RNA molecules, and culminates in the acquisition of a robust migratory phenotype, this cellular model might disclose functions of circRNAs. Here we show that circRNAs of EGF-stimulated mammary cells are stably expressed, while mRNAs and microRNAs change within minutes. In general, the circRNAs we detected are relatively long-lived and weakly expressed. Interestingly, they are almost ubiquitously co-expressed with the corresponding linear transcripts, and the respective, shared promoter regions are more active compared to genes producing linear isoforms with no detectable circRNAs. These findings imply that altered abundance of circRNAs, unlike changes in the levels of other RNAs, might not play critical roles in signaling cascades and downstream transcriptional networks that rapidly commit cells to specific outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“endogenous circRNAs lack the free ends necessary for exonuclease-mediated degradation, rendering them resistant to several mechanisms of RNA turnover and granting them extended lifespans as compared to their linear mRNA counterparts2, 9.”
From Engineering circular RNA for potent and stable translation in eukaryotic cells (2018) · cites this paper as [9]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fast gapped-read alignment with Bowtie 2
Langmead, B., & Salzberg, S. L. (2012) · Nature Methods · doi:10.1038/nmeth.1923 · Cited by 56,400
MicroRNAs: Target Recognition and Regulatory Functions
Bartel, D. P. (2009) · Cell · doi:10.1016/j.cell.2009.01.002 · Cited by 20,068
Heinz, S., Benner, C., Spann, N., Bertolino, E., Lin, Y. C., Laslo, P., Cheng, J. X., Murre, C., Singh, H., & Glass, C. K. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.05.004 · Cited by 13,382
Circular RNAs are a large class of animal RNAs with regulatory potency
Memczak, S., Jens, M., Elefsinioti, A., Torti, F., Krueger, J., Rybak, A., Maier, L., Mackowiak, S. D., Gregersen, L. H., Munschauer, M., et al. (2013) · Nature · doi:10.1038/nature11928 · Cited by 7,990
Natural RNA circles function as efficient microRNA sponges
Hansen, T. B., Jensen, T. I., Clausen, B. H., Bramsen, J. B., Finsen, B., Damgaard, C. K., & Kjems, J. (2013) · Nature · doi:10.1038/nature11993 · Cited by 7,985
Li, J.-H., Liu, S., Zhou, H., Qu, L.-H., & Yang, J.-H. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt1248 · Cited by 4,686
Circular RNAs are abundant, conserved, and associated with ALU repeats
Jeck, W. R., Sorrentino, J. A., Wang, K., Slevin, M. K., Burd, C. E., Liu, J., Marzluff, W. F., & Sharpless, N. E. (2013) · RNA · doi:10.1261/rna.035667.112 · Cited by 4,388
The multilayered complexity of ceRNA crosstalk and competition
Tay, Y., Rinn, J., & Pandolfi, P. P. (2014) · Nature · doi:10.1038/nature12986 · Cited by 3,910
MicroRNA Targeting Specificity in Mammals: Determinants beyond Seed Pairing
Grimson, A., Farh, K. K.-H., Johnston, W. K., Garrett-Engele, P., Lim, L. P., & Bartel, D. P. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.06.017 · Cited by 3,766
circRNA biogenesis competes with pre-mRNA splicing
Ashwal-Fluss, R., Meyer, M., Pamudurti, N. R., Ivanov, A., Bartok, O., Hanan, M., Evantal, N., Memczak, S., Rajewsky, N., & Kadener, S. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.08.019 · Cited by 3,083
Flagged first, then by citations
2 of the 64 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 501–600 of 765
Targeted RNA base editing for therapeutic: mechanisms and advances
Yan, W., & Weng, X. (2025) · Pharmaceutical Science Advances · doi:10.1016/j.pscia.2025.100089 · Cited by 5
Splint-free circular RNA synthesis via RNA secondary structure–guided ligation
Kim, Y.-C., Kang, D. H., Choi, K., Yoo, Y.-J., Kim, H. J., Choi, S.-S., Kang, S.-H., & Kim, E.-S. (2025) · New Biotechnology · doi:10.1016/j.nbt.2025.12.004 · Cited by 5
Current Understandings and Open Hypotheses on Extracellular Circular RNAs
Verwilt, J., & Vromman, M. (2024) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1872 · Cited by 6
Targeting Regulatory Noncoding RNAs in Human Cancer: The State of the Art in Clinical Trials
Piergentili, R., & Sechi, S. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17040471 · Cited by 5
CircRNAs: emerging factors for regulating glucose metabolism in colorectal cancer
Liu, Y., Jiang, C., Liu, Q., Huang, R., Wang, M., & Guo, X. (2023) · Clinical & Translational Oncology · doi:10.1007/s12094-023-03131-7 · Cited by 5
Circular RNAs as novel biomarkers in glomerular diseases
Hejazian, S. M., Saadat, Y. R., Khatibi, S. M. H., Farnood, F., Farzamikia, N., Hejazian, S. S., Batoumchi, S., Shoja, M. M., Vahed, S. Z., & Ardalan, M. (2023) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2023.2212328 · Cited by 5
“2018) because of their high lifespan and resistance to degradation by exonuclease (enuka et al .”
Circular RNA and intervertebral disc degeneration: unravelling mechanisms and implications
Xie, G., Wu, T., Ji, G., Wu, H., Lai, Y., Wei, B., & Huang, W. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1302017 · Cited by 5
“Their half-life is at least 2-fold longer than that of linear RNAs, exceeding 48 h (Jeck et al., 2013; Enuka et al., 2016), and for some genes, they are 10-fold more abundant than the associated linear mRNAs (Borchardt et al., 2017).”
BackgroundCircular RNAs: Regulators of endothelial cell dysfunction in atherosclerosis
Jin, T., Wang, H., Liu, Y., & Wang, H. (2024) · Journal of Molecular Medicine · doi:10.1007/s00109-023-02413-5 · Cited by 5
“Compared to mRNAs, circR-NAs have several advantages, such as remarkable stability, a longer half-life [170, 171], simple production and storage [169], and the ability to encode proteins.”
Circular RNAs in tuberculosis and lung cancer
Jabeen, S., Ahmed, N., Rashid, F., Lal, N., Kong, F., Fu, Y., & Zhang, F. (2024) · Clinica Chimica Acta · doi:10.1016/j.cca.2024.119810 · Cited by 6
circAFF2 promotes the development of AML by binding to PML mRNA
Lei, Y., Zhang, X., Li, X., Xu, J., Yang, S., Li, F., Chen, W., Shan, Y., Ren, L., Zhuo, C., et al. (2025) · Oncogene · doi:10.1038/s41388-025-03299-y · Cited by 6
“As an important member of non-coding regulatory RNA, circRNA is widely expressed in human tissues and plays a role in regulating gene expression [11].”
Structural Properties of Small Single-Stranded Circular Nucleic Acids
Chaturvedi, P., & Vuković, L. (2019) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.9b06831 · Cited by 7
Deng, L., Yang, J., & Liu, H. (2020) · IEEE International Conference on Bioinformatics and Biomedicine (BIBM) · doi:10.1109/bibm49941.2020.9313215 · Cited by 5
Huang, H., Luo, H., Wei, N., Liu, M.-L., He, F., Yang, W. C., Dong, J., Yang, X., & Li, F. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-02792-5 · Cited by 5
“Compared with other ncRNAs, circRNAs are resistant to degradation due to their circular structure [57, 58].”
BackgroundSharkawi, F. Z. E., El-Sherbiny, M., Ali, S. A. M., & Nassif, W. M. H. (2022) · Gastroenterología y Hepatología · doi:10.1016/j.gastrohep.2022.03.006 · Cited by 5
L’Abbate, A., Tolomeo, D., Cifola, I., Severgnini, M., Turchiano, A., Augello, B., Squeo, G. M., D’Addabbo, P., Traversa, D., Daniele, G., et al. (2017) · Leukemia · doi:10.1038/leu.2017.337 · Cited by 5
Chellini, L., Palombo, R., Riccioni, V., & Paronetto, M. P. (2022) · Cancers · doi:10.3390/cancers14194677 · Cited by 5
“CircRNAs are involved at different levels in the regulation of cellular homeostasis and are characterized by tissue-specific expression patterns [129,130] and high stability [131].”
BackgroundThe Epigenetics of Noncoding RNA
Chhabra, R. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91909-8.00010-4 · Cited by 5
Advances in mRNA vaccines for viral diseases
Huang, Y., Zhu, X., Guo, X., Zhou, Y., Liu, D., Mao, J., Xiong, Y., Deng, Y., & Gao, X. (2023) · Journal of Medical Virology · doi:10.1002/jmv.28924 · Cited by 5
“leads to SAM vaccines having large and complex SAM sequences, which puts more demands on SAM delivery systems.(195)”
BackgroundOrbitofrontal intronic circular RNA from Nrxn3 mediates reward learning and motivation for reward
Dabrowski, K. R., Floris, G., Gillespie, A., & Daws, S. E. (2023) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2023.102546 · Cited by 6
Non-coding RNAs: Circular RNAs (circRNAs)
Saw, P. E., & Song, E. (2025) · Springer eBooks · doi:10.1007/978-981-96-3041-7_7 · Cited by 5
Umer, M., Anwar, N., Mubeen, M., Iftikhar, Y., Solanki, M. K., Zeshan, M., Syaad, K. M. A., Li, Y., & Liu, P. (2025) · Physiological and Molecular Plant Pathology · doi:10.1016/j.pmpp.2025.102800 · Cited by 4
Wang, Q., Tjokrodirijo, R. T. N., Mei, H., van Veelen, P. A., ten Dijke, P., & Fan, C. (2025) · Cell Death and Differentiation · doi:10.1038/s41418-025-01597-2 · Cited by 4
“Their circular structure confers increased resistance to exonuclease-mediated degradation (e.g., by RNase R), resulting in enhanced stability than their cognate linear mRNAs [25, 26].”
Circular RNA in hepatocellular carcinoma: emerging therapeutic strategies
Jazbec, G., & Režen, T. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1722576 · Cited by 4
CircRM: profiling circular RNA modifications from nanopore direct RNA sequencing
Li, J., Chen, S., Wu, Z., Wang, H., Xia, R., Meng, J., & Zhang, Y. (2025) · Briefings in Bioinformatics · doi:10.1093/bib/bbaf726 · Cited by 4
Pan, Y., Li, X., Zhou, B., Zhuang, Y., Luo, L., Zhu, C., Xu, R., Jiang, Y., Dong, Y., Hao, Z., et al. (2026) · Journal of the American Chemical Society · doi:10.1021/jacs.6c04991 · Cited by 4
Shi, H., & Kong, S. (2024) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2024.102367 · Cited by 4
Circular RNA oligonucleotides: enzymatic synthesis and scaffolding for nanoconstruction
Li, S., Chu, Y., Guo, X., Mao, C., & Xiao, S. (2024) · Nanoscale Horizons · doi:10.1039/d4nh00236a · Cited by 4
Gao, L., Juan, J., Zheng, Z., & Huang, L. (2024) · Toxics · doi:10.3390/toxics12120917 · Cited by 4
Circular RNA profiles of osteoarthritic synovium
Liu, P., Gao, G., Zhou, X., Zhang, X., Cai, Q., Xiang, Z., Shen, X., & Wu, X. (2022) · Molecular Omics · doi:10.1039/d2mo00066k · Cited by 4
Riddle of the Sphinx: Emerging role of circular RNAs in cervical cancer
Yin, C., Yu, J., Liu, G., He, J., & Wu, P. (2024) · Pathology - Research and Practice · doi:10.1016/j.prp.2024.155315 · Cited by 4
Non‐coding RNAs and their potential exploitation in cancer therapy‐related cardiotoxicity
Bernasconi, R., & Kuster, G. M. (2024) · British Journal of Pharmacology · doi:10.1111/bph.16416 · Cited by 4
“Moreover, circRNAs are more stable and have a longer half-life than linear RNAs (Enuka et al., 2016), making them prime candidates as biomarkers (Zhao et al., 2022).”
Liquid biopsy as a perioperative biomarker of digestive tract cancers: review of the literature
Shoda, K., Saito, R., Maruyama, S., Furuya, S., Akaike, H., Kawaguchi, Y., Amemiya, H., Kawaida, H., Sudo, M., Inoue, S., et al. (2020) · Surgery Today · doi:10.1007/s00595-020-02148-7 · Cited by 4
Liang, D., Tatomer, D. C., & Wilusz, J. E. (2021) · Methods · doi:10.1016/j.ymeth.2021.04.012 · Cited by 4
Diverse Roles and Therapeutic Potentials of Circular RNAs in Urological Cancers
Wang, S., Ying, Y., Ma, X., Wang, W., Wang, X., & Xie, L. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.761698 · Cited by 4
Kasprzyk, M. E., Kazimierska, M., Sura, W., Dzikiewicz‐Krawczyk, A., & Podralska, M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-90406-3.00010-5 · Cited by 6
The mysterious circle: Molecular curiosities of RNA mediated gene regulation
Seth, K., & Harish (2017) · Gene Reports · doi:10.1016/j.genrep.2017.08.001 · Cited by 4
What is the role of circRNAs in the pathogenesis of cervical cancer? A systematic literature review
Matos, A. G. D. M., Silva, G. E. B., Barbosa, E. D. S., de Andrade, M. S., Lages, J. S., Corrêa, R. D. G. C. F., Oliveira, A. G. C., Teixeira, E. B., da Silva, M. G. D. O. P., da Fonseca, S. S. S., et al. (2024) · Frontiers in Genetics · doi:10.3389/fgene.2024.1287869 · Cited by 3
Circular RNAs from the MAPT and TARDBP genes: Novel players in neurodegeneration?
Bagheri, N., Margvelani, G., Chiang, T.-W., Nelson, P. T., Chuang, T., & Stamm, S. (2025) · Neurochemistry International · doi:10.1016/j.neuint.2025.106019 · Cited by 3
A review on circular RNAs in helminth parasites: Insights and potential applications
Giri, B. R., & Cheng, G. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.148956 · Cited by 3
Chen, H., Zhang, J., Huang, J., Wu, Z., Tang, L., Tian, Y., Gao, S., Huang, S., Cao, J., Chen, J., et al. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-07470-7 · Cited by 3
“The ‘high-yield, scarless’ Hi-Scarless-PIE system developed in this study also addresses the limitations of conventional PIE platforms—either ‘scar sequences triggering immunogenicity’ or ‘scarless designs causing low yield [104], highlighting its potential as an advanced form of CAR delivery (Fig.”
InfluentialZiaei, A., Kargar, M., Shirvani-Farsani, Z., & MehrabMohseni, M. (2026) · Biomarker Research · doi:10.1186/s40364-025-00886-9 · Cited by 4
“This unique structure, which lacks free 5‘and 3’ ends, confers exceptional stability to RNA exonucleases and gives circRNAs a much longer half-life than their linear counterparts [10].”
Ren, Y., Xu, Y., Liu, M., Zhang, L., Song, Y., Li, J., Liu, J., Fan, D., Zhang, Z., He, J., et al. (2026) · New Phytologist · doi:10.1111/nph.70962 · Cited by 3
“Although their abundance is relatively low in tissues, most circRNAs have long half-lives because of their resistance to degradation mechanisms, implying that they have the potential to play vital roles (Enuka et al ., 2016).”
Zhang, Y., Zhang, J.-P., & Zhang, X.-B. (2026) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2026.1838589 · Cited by 3
“…RNAs (circRNAs) present an important design contrast to linear mRNAs: their covalently closed structure confers strong resistance to exonucleases (Enuka et al., 2016), whereas the absence of a 5 ′ cap and 3 ′ tail has historically limited translational efficiency relative to linear mRNA (Legnini…”
Stroke triggers dynamic m6A reprogramming of cerebral circular RNAs
Mehta, S. L., Namous, H., & Vemuganti, R. (2024) · Neurochemistry International · doi:10.1016/j.neuint.2024.105802 · Cited by 3
Viroids and Retrozymes: Plant Circular RNAs Capable of Autonomous Replication
Lezzhov, A. A., Atabekova, A. K., Chergintsev, D. A., Lazareva, E. A., Solovyev, A. G., & Morozov, S. Y. (2024) · Plants · doi:10.3390/plants14010061 · Cited by 3
“One of the main advantages of circRNAs over mRNAs is their potentially higher stability, which is an important factor in many applications [10].”
Research progress of circRNAs in bone-related diseases
Hua, X., Yu, L., Zhu, H., Zhu, Y., Fan, G., & Zhou, G. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1481322 · Cited by 3
Molecular basis of backsplicing regulation and its application to manipulate circRNA levels
Wang, Y., Dzakah, E. E., & Wang, X. (2025) · RNA Biology · doi:10.1080/15476286.2025.2525914 · Cited by 3
Techniques for Analyzing Genome-wide Expression of Non-coding RNA
Onoguchi‐Mizutani, R., Taniue, K., Kawata, K., Yamada, T., & Akimitsu, N. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91909-8.00039-6 · Cited by 3
Liu, Q., Liu, X., Wang, H.-M., Xu, L., Zhao, X., Han, S.-G., & Lu, Z.-H. (2023) · Journal of Genetics · doi:10.1007/s12041-023-01442-w · Cited by 3
“Therefore, it is an ideal disease biomarker for a variety of diseases (Jeck et al. 2013; Enuka et al. 2016).”
BackgroundCircRNA: a rising therapeutic strategy for lung injury induced by pulmonary toxicants
Liao, C., He, Z.-W., Yu, R., Yu, Y., Liu, X., Kong, D., & Wang, Y. (2024) · Archives of Toxicology · doi:10.1007/s00204-024-03706-5 · Cited by 4
“…of circRNAs––they Cai Liao and Zhen-Wei He have contributed equally to this work. are more stable and have a longer lifespan because of their covalent closed-loop structure, which keeps them from being broken down by exoribonuclease ribonuclease (RNase) R (Enuka et al. 2016; Jeck et al. 2013).”
Progress in application of cyclic single-stranded nucleic acids
Liu, X.-Y., Tong, J.-F., Li, M.-Y., Li, L.-F., Cai, W.-W., Li, J.-Q., Wang, L., & Sun, M. (2024) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2024.07.017 · Cited by 5
Jakobsen, T., Pløen, G. G., Behsen, A. D., Møller, H. J., Plesner, T., Dybkær, K., Andersen, M. N., Misund, K., & Kristensen, L. S. (2024) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.70215 · Cited by 3
“This closed-loop structure makes cir-cRNAs more stable than linear RNAs [14–16].”
Sun, Z., Lu, L., Liu, L., Liang, R., Zhang, Q., Liu, Z., An, J., Liu, Q., Wu, Q., Wei, S., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1574568 · Cited by 4
A circuitous route to GBM stem cell signalling
Mitchell, K., & Lathia, J. D. (2021) · Nature Cell Biology · doi:10.1038/s41556-021-00643-8 · Cited by 3
Иванович, В. В., Chuklovin, A. B., & Shabanov, P. D. (2023) · Reviews on Clinical Pharmacology and Drug Therapy · doi:10.17816/rcf204335-384 · Cited by 3
Sun, W., Zhou, C., Peng, C., Yang, R., Li, M., Geng, J., Zhou, J., Chen, L., & Li, W. (2023) · Laboratory Medicine · doi:10.1093/labmed/lmad101 · Cited by 2
Opportunities in Therapeutic mRNA Stabilization: Sequence, Structure, Adjuvants and Vectors
Choe, J. A., Burger, J. C., Jones, J., Panjla, A., & Murphy, W. L. (2025) · Advanced Therapeutics · doi:10.1002/adtp.202400537 · Cited by 3
Activation of the circAGFG1/miR-195-5p/PD-L1 axis induces lung injury in sepsis
Bi, Y., Ding, R., Liu, X., He, Y., Liu, X., Ma, S., Wang, C., Zhang, Z., & Song, X. (2025) · Human Cell · doi:10.1007/s13577-025-01258-z · Cited by 2
“This sponging effect was further confirmed through over-expression and silencing experiments, which showed that circAGFG1 modulates PD-L1 expression by sequestering miR-195-5p [56, 57].”
Circular RNAs in Brain Physiology and Neurologic Diseases
AmeliMojarad, M., & AmeliMojarad, M. (2025) · Advances in experimental medicine and biology · doi:10.1007/978-981-96-9428-0_23 · Cited by 2
Learning and memory in molecular networks
Lissek, T. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.152805 · Cited by 3
A Comprehensive Insight Into the Roles of Exosomal circRNAs in Metabolic Syndrome
Taherpour, A., Ebrahimi, S., & Mirzavi, F. (2025) · BioFactors · doi:10.1002/biof.70053 · Cited by 2
“In ac-tuality, circRNA stability is 2.5–5 times greater than that of linear transcript stability [26].”
InfluentialMilov, A., Nikolova, M., Mandadzhieva, S. K., Doncheva, N., Milova, N., & Yordanov, A. D. (2025) · Epigenomes · doi:10.3390/epigenomes9040047 · Cited by 2
“More than 90% of human genes have isoforms [2].”
Enhancing Circular RNA Translation Efficiency Through Dual Internal Ribosome Entry Sites
Sun, Y., Zhang, Y., Chen, W., CHEN, T., Zhang, Y., Zhang, S., & Lu, C. (2026) · Biology · doi:10.3390/biology15040317 · Cited by 2
“In contrast, covalently closed circRNAs lack free ends susceptible to exonuclease attack, thereby exhibiting enhanced stability and prolonged persistence in cells [7,8].”
Sadaqa, E., Fajriawan, A. A., & Muttaqien, S. E. (2026) · Biointerface Research in Applied Chemistry · doi:10.33263/briac161.028 · Cited by 4
Tian, B., Cai, Q., Xiao, Z., Cai, D., Ou, Y., Wang, M., Renyong, J., Chen, S., Zhu, D., Mafeng, L., et al. (2026) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2026.151095 · Cited by 2
Long-Read Sequencing Reveals RNA Splicing Complexity in Human Diseases
Tan, X., Wang, P., Li, Y., Yuan, B., Sun, Q., & Liu, Y. (2026) · Computational and Structural Biotechnology Journal · doi:10.34133/csbj.0052 · Cited by 2
“Owing to their closed-loop structure, circRNAs exhibit longer half-lives than linear RNAs and are resistant to exonuclease degradation [ 60 ].”
An, J. S., Lim, S. B., Lee, K. H., Kim, S., Kim, S., Lee, J., Kim, D., Han, S. R., Naito, M., Miyata, K., et al. (2026) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.5c02147 · Cited by 2
“18 Unlike linear mRNA, circular RNA does not require 5 ′ cap analogs, modified nucleotides such as N1-methyl-pseudouridine (m1 ψ ), 19 or a 3 ′ poly(A) tail for translation and stability.”
Translatable Circular RNAs are Degraded Via Nonsense-mediated mRNA Decay
Kang, E., Kang, D., Cho, Y. K., Shin, M., Boo, S. H., Chang, J., Kim, H., Jo, J. H., & Kim, Y. K. (2026) · Journal of Molecular Biology · doi:10.1016/j.jmb.2026.169828 · Cited by 2
In vitro transcribed circRNA as a therapeutic agent for cancer
Xu, S., Zhao, Y., Tang, Y., Fu, G., Qian, C., Li, F., Yang, Z., Cui, W., & Cai, W. (2026) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2026.04.019 · Cited by 3
Circular RNAs in animals: Biogenesis, function and cell fate control
Mohammad, R., Parfyonova, Y. V., & Сергеевич, С. Ю. (2026) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2026.195154 · Cited by 2
Circular RNA: the rings of power over cell
Gordiyuk, V. V., & Mankovska, O. S. (2020) · Biopolymers and Cell · doi:10.7124/bc.000a23 · Cited by 2
Loss of circIGF1R Suppresses Cardiomyocytes Proliferation by Sponging miR-362-5p
Zeng, J., Li, H.-J., Liu, K., Liang, C., Wu, H., Chen, W.-Y., Tang, M., Zhao, W., Cai, D., & Qi, X. (2023) · DNA and Cell Biology · doi:10.1089/dna.2022.0590 · Cited by 2
Comprehensive analysis of circular RNAs in nasopharyngeal cancer
Zhu, S., Wang, X., Xie, H., & Liu, L. (2023) · Genes & Genomics · doi:10.1007/s13258-023-01438-x · Cited by 2
Application of self-amplifying mRNA technology in the development of infectious disease vaccines
Li, X., Wang, X., & Zhang, B. (2023) · Chinese Science Bulletin (Chinese Version) · doi:10.1360/tb-2023-0902 · Cited by 3
Tian, X.-L., Zhang, T., Cai, T.-J., Tian, M., & Liu, Q.-J. (2024) · International Journal of Radiation Biology · doi:10.1080/09553002.2024.2304850 · Cited by 2
“Several studies have corroborated that circRNAs possess longer half-lives than their corresponding linear RNAs (Jeck et al. 2013; Enuka et al. 2015).”
BackgroundInfluentialDeğirmençay, Ş., Özdemir, S., Küçükler, S., Bayat, R., & Kadak, M. (2025) · Veterinary Medicine and Science · doi:10.1002/vms3.70344 · Cited by 2
Biogenesis, function and role of circular RNA in Gall Bladder Carcinoma-A narrative review
Singh, A. K., Anand, N., & Srivastava, P. (2025) · Surgical and Experimental Pathology · doi:10.1186/s42047-025-00188-2 · Cited by 2
Non-coding RNAs in cardiac remodeling: diversity in composition and function
Chatterjee, E., & Das, S. (2022) · Current Opinion in Physiology · doi:10.1016/j.cophys.2022.100534 · Cited by 2
Kumar, R., & Lahiri, T. (2018) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2018.08.002 · Cited by 2
Advances in studies of ncRNAs in the pathophysiology and treatment of spinal disease
Wang, J., Wei, W., Jia, Y., & Xi, Y. J. X. (2022) · General Physiology and Biophysics · doi:10.4149/gpb_2021039 · Cited by 2
Yue, W., Ye, Y., Chen, B., Wu, D., Wang, H., & Hui, G. (2023) · PubMed · doi:10.14670/hh-18-567 · Cited by 2
Ueno, D., Mikami, M., Yamasaki, S., Kaneko, M., Mukuta, T., Demura, T., & Kato, K. (2020) · Plant and Cell Physiology · doi:10.1093/pcp/pcaa147 · Cited by 3
Razzaghi, H., Heiat, M., Khoncheh, A., Abyazi, M. A., & Zaki‐Dizaji, M. (2024) · Reports of Biochemistry and Molecular Biology · doi:10.61186/rbmb.13.3.368 · Cited by 1
Saw, P. E., & Song, E. (2025) · Springer eBooks · doi:10.1007/978-981-96-3041-7_27 · Cited by 1
Pharmaceutical perspectives on oligonucleotide therapeutics and delivery systems
Staller, D. W., Gawargi, F. I., Panigrahi, S. S., Mishra, P. K., & Mahato, R. I. (2025) · Pharmacological Reviews · doi:10.1016/j.pharmr.2025.100065 · Cited by 1
The Role of Long Non-Coding RNAs in Skeletal Muscle Pathophysiology: A Therapeutic Perspective
Scalabrin, S., Kavoosi, S., & Cagnin, S. (2025) · Genetics. · doi:10.5772/intechopen.1009960 · Cited by 1
CircRSF1: A potential diagnostic biomarker for primary Sjögren's syndrome
Wang, Y., Ma, H., Du, L., Chen, Q., Su, Y., Guan, C., & Wang, X. (2025) · Life Sciences · doi:10.1016/j.lfs.2025.123794 · Cited by 1
Circular RNAs as Biomarkers in the Diagnosis of Human Diseases
Özdemir, S. (2025) · Advances in experimental medicine and biology · doi:10.1007/978-981-96-9428-0_14 · Cited by 1
The advantage of periodic over constant signalling in microRNA-mediated regulation
Ferro, E., Szischik, C. L., Ventura, A. C., & Bosia, C. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkaf867 · Cited by 2
“For instance, the half-lives of circRNAs were shown to be on average 2.5 times longer than those of mRNAs [ 70 ]— a difference compatible in our predictions with the possibility of exclusive regulation in frequency.”
InfluentialXia, Z., Liu, W., Guo, D., Chen, L., Zhao, Y., Zhao, Y., Zhang, J., Xia, L., Zou, Y., Sun, P., et al. (2025) · Cancer Research · doi:10.1158/0008-5472.can-25-0738 · Cited by 1
Non‑coding RNAs in epithelial‑mesenchymal transition of renal cell carcinoma (Review)
Liu, Z., Zhou, H., Shen, J., Qi, Y., Gong, X., & Zhang, C. L. (2025) · Molecular Medicine Reports · doi:10.3892/mmr.2025.13761 · Cited by 2
“…be regulated by other ncrnas, such as circrnas and lncrnas, these molecules can serve as natural inhibitors of oncogenic mirnas. compared with linear rnas, circrnas have a more stable molecular structure, making them less susceptible to degradation by rnases and prolonging their half‑life (147).”
Role of circular RNAs in regulating toxicity induced by cancer therapies
Xian, J., Qadir, J., Yang, B. B., & Ye, T. (2025) · Genes & Diseases · doi:10.1016/j.gendis.2025.101982 · Cited by 1
Cai, Y., Zheng, Z., Xu, H., Zhu, Y., Zepeda, J. C., Grueter, B. A., Wang, X., Ku, T., Duan, Y., Tsang, H. W. S., et al. (2026) · Science Advances · doi:10.1126/sciadv.ads7509 · Cited by 2
“Moreover, the enhanced stability of circHomer1 ( 18 , 77 ) suggests that potential molecular recycling could amplify its functional impact.”
Sun, K., & Wu, H. (2026) · The Analyst · doi:10.1039/d6an00107f · Cited by 1
Circular RNAs: An Under-Recognized Part in Different Scenarios of Host–Parasite Interrelationships
Sharaf, M. S., Ashour, D. S., & Othman, A. A. (2026) · Pathogens · doi:10.3390/pathogens15030307 · Cited by 1
“Their defining feature, a stable closed-loop structure, imparts a significantly longer half-life and enhanced resistance to RNase degradation compared to linear RNAs [81].”
Cao, X., Sui, J., Shan, G., & Liu, X. (2026) · Non-coding RNA Research · doi:10.1016/j.ncrna.2026.03.002 · Cited by 1
Delivery routes and circular mRNA vaccine architecture synergistically shape in vivo immune profiles
Shu, Y., Shen, T., Niu, Y., Xu, Y., Kong, X., Su, M., Yang, X., Yuan, L., Xie, S., Wang, J., et al. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.114912 · Cited by 1
The “cutting edge” of non-canonical RNA splicing
Guo, J. (2026) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2026.1719817 · Cited by 1
“…head-to-tail circular structure, circRNAs lack free 5 ′ and 3 ′ ends and canonical splice junctions, making them largely resistant to exonucleolytic degradation and thereby substantially more stable than their linear RNA counterparts (Jeck et al., 2013; Enuka et al., 2016; Kristensen et al., 2019).”
Circular RNAs in Intestinal Mucosal Homeostasis and Pathologies
Chung, H. K., Xiao, L., & Wang, J.-Y. (2026) · Non-Coding RNA · doi:10.3390/ncrna12030014 · Cited by 1
“Specific RBPs such as quaking can bind to motifs in flanking introns and function through protein–protein interactions, bridging distant splice sites [24,25].”
Zhang, Q., Niu, D., Jia, Y., Lu, L., Qu, C., Qu, C., Sun, Z., Li, S., Liu, Z., Lv, J., et al. (2026) · PLoS Pathogens · doi:10.1371/journal.ppat.1013741 · Cited by 1
“Compared with linear mRNA counterparts, circular RNA exhibits significantly extended half-lives in mammalian cells [23].”
Metadata
- Authors
- Enuka, Y., Lauriola, M., Feldman, M. E., Sas-Chen, A., Ulitsky, I., & Yarden, Y.
- Affiliations
- Weizmann Institute of Science (IL)
- Corresponding author
- Yarden, Yosef
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-12-10
- Volume
- 44
- Issue
- 3
- Pages
- 1370-1383
- ISSN
- 0305-1048 (ISSN-L)
- 1362-4962
- PMC
- PMC4756822
- OpenAlex
- W2285247593
- Cited by
- 757
- References
- 64
- Citations by year
- 2026: 66 · 2025: 91 · 2024: 100 · 2023: 105 · 2022: 93 · 2021: 107 · 2020: 68 · 2019: 57 · 2018: 33 · 2017: 26 · 2016: 9
- FWCI
- 9.85
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nucleic Acids Research (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion, cc-by-nc)
- HighWire Press Open Archive (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Circular RNAs in diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer-related molecular mechanisms research
- Keywords
- circular RNA, epidermal growth factor, mammary epithelial cells, RNA stability, non-coding RNA, microRNA, cell migration, growth factor signaling
- MeSH terms
- RNA, Circular, Breast, Cell Line, Epidermal Growth Factor, Epithelial Cells, Humans, RNA, RNA, Messenger, Gene Expression, Transforming Growth Factor alpha, Reverse Transcriptase Polymerase Chain Reaction, Oligonucleotide Array Sequence Analysis, Gene Expression Profiling, RNA Stability, MicroRNAs, Heparin-binding EGF-like Growth Factor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review